Homozygous variant rs2076530 of BTNL2 and familial sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 26, Issue 2, 2009, Pages 162-166

  Coudurier, M ^a   Freymond, N ^a   Aissaoui, S ^a   Calender, A ^a   Pacheco, Y ^a   Devouassoux, G ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

BTNL2; Co stimulatory molecule; Familial sarcoidosis; Rs2076530 SNP

Indexed keywords

ADULT; ALLELE; ARTICLE; BTNL2 GENE; CLINICAL ARTICLE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FEMALE; GENE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; INFECTION; MALE; PENETRANCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SARCOIDOSIS; T LYMPHOCYTE ACTIVATION;

ADULT; ALLELES; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MUTATION; PEDIGREE; POLYMERASE CHAIN REACTION; SARCOIDOSIS;

EID: 77649248743     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Pietinalho A, Ohmichi M, Hirasawa M, et al. Familial sarcoidosis in Finland and Hokkaido, Japan - a comparative study. Respir Med 1999; 93: 408-12.
2. Valentonyte R, Hampe J, Huse K, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005; 37: 357-64.
3. Rhodes DA, Stammers M, Malcherek G, et al. The cluster of BTN genes in the extended major histocompatibility complex. Genomics 2001; 71: 351-62.
4. Nguyen T, Liu XK, Zhang Y, et al. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation. J Immunol 2006; 176: 7354-60.
5. Martenstein H. Knochveranderunger bei lupus pernio. Zentralb Haut Geschl Kr 1923; 7: 308-12.
6. British Thoracic and Tuberculosis Association. Familial associations in sarcoidosis. Tubercle 1973; 54: 87-98.
7. James DJ, Hosoda Y. Epidemiology. In: James DJ, ed. Sarcoidosis and other granulomatous disorders. New York, Marcel Dekker Inc. 1994, 729-44.
8. Brennan NJ, Crean P, Long JP, et al. High prevalence of familial sarcoidosis in an Irish population. Thorax 1984; 39: 14-8.
9. Rybicki BA, Harrington D, Major M, et al. Heterogeneity of familial risk in sarcoidosis. Genet Epidemiol 1996; 13: 23-33.
10. Rybicki BA, Maliarik MJ, Major M, et al. Genetics of sarcoidosis. Clin Chest Med 1997; 18: 707-17.
11. Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001; 164: 2085-91.
12. El Hassani S, el Maghraoui A, Bensabbah R, et al. Familial sarcoidosis: three case reports]. Rev Med Interne 1998; 19: 199-202.
13. Elford J, Fitch P, Kaminski E, et al. Five cases of sarcoidosis in one family: a new immunological link? Thorax 2000; 55: 343-4.
14. Rybicki BA, Kirkey KL, Major M, et al. Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol 2001; 153: 188-93.
15. Fité E, Alsina JM, Antó JM, et al. Sarcoidosis: family contact study. Respiration 1998; 65: 34-9.
16. Nassif X, Valeyre D, Loiseau A, et al. Familial sarcoidosis. A propos of 22 families. Ann Med Interne (Paris) 1985; 136: 611-4.
17. Judson MA, Hirst K, Iyengar SK, Rybicki BA, et al. SAGA Study Consortium.Comparison of sarcoidosis phenotypes among affected African-American siblings. Chest 2006; 130: 855-62.
18. Li Y,Wollnik B, Pabst S, et al. BTNL2 gene variant and sarcoidosis. Thorax 2006; 61: 273-4.
19. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336: 1224-34.
20. Prezant DJ, Dhala A, Goldstein A, et al. The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest 1999; 116: 1183-93.
21. Wilsher ML. Seasonal clustering of sarcoidosis presenting with erythema nodosum. Eur Respir J 1998; 12: 1197-9.
22. Padilla ML, Schilero GJ, Teirstein AS. Sarcoidosis and transplantation. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 16-22.
23. Parkes SA, Baker SB, Bourdillon RE, et al. Epidemiology of sarcoidosis in the Isle of Man-1: A case controlled study. Thorax 1987; 42: 420-6.
24. Müller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 1998; 12: 716-38.
25. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-73.
26. James DG. Epidemiology of sarcoidosis. Sarcoidosis 1992; 9: 79-87.
27. Rybicki BA, Kirkey KL, Major M, et al. Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol 2001; 153: 188-93.
28. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987; 135: 747-60.
29. Arnett HA, Escobar SS, Gonzalez-Suarez E, et al. BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation. J Immunol 2007; 178: 1523-33.